Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-22-000041
Filing Date
2022-04-22
Accepted
2022-04-22 10:31:08
Documents
3
Period of Report
2022-04-22

Document Format Files

Seq Description Document Type Size
1 6-K form6kbloomburton.htm 6-K 18300
2 EX-99.1 oncybloomburton.htm EX-99.1 16046
3 image_0.jpg GRAPHIC 933863
  Complete submission text file 0001129928-22-000041.txt   1321706
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 22844137
SIC: 2834 Pharmaceutical Preparations